Intra-individual comparison of 68Ga-PSMA-11 and 18F-DCFPyL normal-organ biodistribution
Abstract Purpose Detailed data comparing the biodistribution of PSMA radioligands is still scarce, raising concerns regarding the comparability of different compounds. We investigated differences in normal-organ biodistribution and uptake variability between the two most commonly PSMA tracers in cli...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2019-05-01
|
| Series: | Cancer Imaging |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s40644-019-0211-y |
| _version_ | 1818721345124433920 |
|---|---|
| author | Gonçalo Ferreira Amir Iravani Michael S. Hofman Rodney J. Hicks |
| author_facet | Gonçalo Ferreira Amir Iravani Michael S. Hofman Rodney J. Hicks |
| author_sort | Gonçalo Ferreira |
| collection | DOAJ |
| description | Abstract Purpose Detailed data comparing the biodistribution of PSMA radioligands is still scarce, raising concerns regarding the comparability of different compounds. We investigated differences in normal-organ biodistribution and uptake variability between the two most commonly PSMA tracers in clinical use, 68Ga-PSMA-11 and 18F-DCFPyL. Methods This retrospective analysis included 34 patients with low tumor burden referred for PET/CT imaging with 68Ga-PSMA-11 and subsequently 18F-DCFPyL. Images were acquired with 4 cross-calibrated PET/CT systems. Volumes of interest were placed on major salivary and lacrimal glands, liver, spleen, duodenum, kidneys, bladder, blood-pool and muscle. Normal-organ biodistribution of both tracers was then quantified as SUVpeak and compared using paired tests, linear regression and Bland-Altman analysis. Between-patient variability was also assessed. Clinical and protocol variables were investigated for possible interference. Results For both tracers the highest uptake was found in the kidneys and bladder and low background activity was noted across all scans. In the quantitative analysis there was significantly higher uptake of 68Ga-PSMA-11 in the kidneys, spleen and major salivary glands (p < 0.001), while the liver exhibited slightly higher 18F-DCFPyL uptake (p = 0.001, mean bias 0.79 ± 1.30). The lowest solid-organ uptake variability was found in the liver (COV 21.9% for 68Ga-PSMA-11, 22.5% for 18F-DCFPyL). There was a weak correlation between 18F-DCFPyL uptake time and liver SUVpeak (r = 0.488, p = 0.003) and, accordingly, patients scanned at later time-points had a larger mean bias between the two tracers’ liver uptake values (0.05 vs 1.46, p = 0.001). Conclusion Normal tissue biodistribution patterns of 68Ga-PSMA-11 and 18F-DCFPyL were similar, despite subtle differences in quantitative values. Liver uptake showed an acceptable intra-patient agreement and low inter-patient variability between the two tracers, allowing its use as a reference organ for thresholding scans in the qualitative comparison of PSMA expression using these different tracers. |
| first_indexed | 2024-12-17T20:37:15Z |
| format | Article |
| id | doaj.art-d15c539b39414eabaf9b28506a543b07 |
| institution | Directory Open Access Journal |
| issn | 1470-7330 |
| language | English |
| last_indexed | 2024-12-17T20:37:15Z |
| publishDate | 2019-05-01 |
| publisher | BMC |
| record_format | Article |
| series | Cancer Imaging |
| spelling | doaj.art-d15c539b39414eabaf9b28506a543b072022-12-21T21:33:25ZengBMCCancer Imaging1470-73302019-05-0119111010.1186/s40644-019-0211-yIntra-individual comparison of 68Ga-PSMA-11 and 18F-DCFPyL normal-organ biodistributionGonçalo Ferreira0Amir Iravani1Michael S. Hofman2Rodney J. Hicks3Nuclear Medicine Department, Instituto Português de Oncologia do PortoCentre for Molecular Imaging, Department of Cancer Imaging, Peter MacCallum Cancer CentreCentre for Molecular Imaging, Department of Cancer Imaging, Peter MacCallum Cancer CentreCentre for Molecular Imaging, Department of Cancer Imaging, Peter MacCallum Cancer CentreAbstract Purpose Detailed data comparing the biodistribution of PSMA radioligands is still scarce, raising concerns regarding the comparability of different compounds. We investigated differences in normal-organ biodistribution and uptake variability between the two most commonly PSMA tracers in clinical use, 68Ga-PSMA-11 and 18F-DCFPyL. Methods This retrospective analysis included 34 patients with low tumor burden referred for PET/CT imaging with 68Ga-PSMA-11 and subsequently 18F-DCFPyL. Images were acquired with 4 cross-calibrated PET/CT systems. Volumes of interest were placed on major salivary and lacrimal glands, liver, spleen, duodenum, kidneys, bladder, blood-pool and muscle. Normal-organ biodistribution of both tracers was then quantified as SUVpeak and compared using paired tests, linear regression and Bland-Altman analysis. Between-patient variability was also assessed. Clinical and protocol variables were investigated for possible interference. Results For both tracers the highest uptake was found in the kidneys and bladder and low background activity was noted across all scans. In the quantitative analysis there was significantly higher uptake of 68Ga-PSMA-11 in the kidneys, spleen and major salivary glands (p < 0.001), while the liver exhibited slightly higher 18F-DCFPyL uptake (p = 0.001, mean bias 0.79 ± 1.30). The lowest solid-organ uptake variability was found in the liver (COV 21.9% for 68Ga-PSMA-11, 22.5% for 18F-DCFPyL). There was a weak correlation between 18F-DCFPyL uptake time and liver SUVpeak (r = 0.488, p = 0.003) and, accordingly, patients scanned at later time-points had a larger mean bias between the two tracers’ liver uptake values (0.05 vs 1.46, p = 0.001). Conclusion Normal tissue biodistribution patterns of 68Ga-PSMA-11 and 18F-DCFPyL were similar, despite subtle differences in quantitative values. Liver uptake showed an acceptable intra-patient agreement and low inter-patient variability between the two tracers, allowing its use as a reference organ for thresholding scans in the qualitative comparison of PSMA expression using these different tracers.http://link.springer.com/article/10.1186/s40644-019-0211-y18F-DCFPyL68Ga-PSMA-11PET/CTBiodistributionProstate cancer |
| spellingShingle | Gonçalo Ferreira Amir Iravani Michael S. Hofman Rodney J. Hicks Intra-individual comparison of 68Ga-PSMA-11 and 18F-DCFPyL normal-organ biodistribution Cancer Imaging 18F-DCFPyL 68Ga-PSMA-11 PET/CT Biodistribution Prostate cancer |
| title | Intra-individual comparison of 68Ga-PSMA-11 and 18F-DCFPyL normal-organ biodistribution |
| title_full | Intra-individual comparison of 68Ga-PSMA-11 and 18F-DCFPyL normal-organ biodistribution |
| title_fullStr | Intra-individual comparison of 68Ga-PSMA-11 and 18F-DCFPyL normal-organ biodistribution |
| title_full_unstemmed | Intra-individual comparison of 68Ga-PSMA-11 and 18F-DCFPyL normal-organ biodistribution |
| title_short | Intra-individual comparison of 68Ga-PSMA-11 and 18F-DCFPyL normal-organ biodistribution |
| title_sort | intra individual comparison of 68ga psma 11 and 18f dcfpyl normal organ biodistribution |
| topic | 18F-DCFPyL 68Ga-PSMA-11 PET/CT Biodistribution Prostate cancer |
| url | http://link.springer.com/article/10.1186/s40644-019-0211-y |
| work_keys_str_mv | AT goncaloferreira intraindividualcomparisonof68gapsma11and18fdcfpylnormalorganbiodistribution AT amiriravani intraindividualcomparisonof68gapsma11and18fdcfpylnormalorganbiodistribution AT michaelshofman intraindividualcomparisonof68gapsma11and18fdcfpylnormalorganbiodistribution AT rodneyjhicks intraindividualcomparisonof68gapsma11and18fdcfpylnormalorganbiodistribution |